KRIEGSMAN STEVEN A

10% owner at CYTRX CORP · on record since Mar 22, 2004
Director at CYTRX CORP · on record since Jun 21, 2006
Director at BRADLEY PHARMACEUTICALS INC · on record since Nov 15, 2006
Director at RXI PHARMACEUTICALS CORP · on record since Feb 14, 2008
Director at HYTHIAM INC · on record since Jun 27, 2008
Director at AUTHENTIDATE HOLDING CORP · on record since Sep 2, 2003
Director at CATALYST SEMICONDUCTOR INC · on record since Apr 28, 2015
Chief Executive Officer at CYTRX CORP · on record since Dec 17, 2015

Insider trading activity of KRIEGSMAN STEVEN A

Transactions on record: 178; since Sep 2, 2003

Open-market buys: 2; $51.3K

Open-market sells: 87; $4.9M

Companies traded: 6; last filing Aug 13, 2020

Figures computed from official regulatory filings — .

Companies where KRIEGSMAN STEVEN A has traded

CYTRX CORP36 tx · $3.3M · Aug 13, 2020
RXI PHARMACEUTICALS CORP111 tx · $5.4M · Jun 23, 2015
CATALYST SEMICONDUCTOR INC1 tx · Apr 28, 2015
HYTHIAM INC1 tx · Jul 18, 2008
BRADLEY PHARMACEUTICALS INC23 tx · $2M · Feb 21, 2008
AUTHENTIDATE HOLDING CORP6 tx · $228.6K · Feb 19, 2004

Track record of KRIEGSMAN STEVEN A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of KRIEGSMAN STEVEN A

Co-insiders of KRIEGSMAN STEVEN A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTRX CORP	Aug 13, 2020	Exercise	3,000,000	0.26 USD	$780K	SEC
CYTRX CORP	Aug 13, 2020	Other	-1,164,179	0.67 USD	$780K	SEC
CYTRX CORP	Aug 13, 2020	ExerciseD (derivative)	-3,000,000	0.00 USD	—	SEC
CYTRX CORP	Dec 17, 2019	AwardD (derivative)	3,000,000	0.00 USD	—	SEC
CYTRX CORP	Dec 19, 2017	Award	387,597	1.75 USD	$678.3K	SEC
CYTRX CORP	Dec 19, 2017	AwardD (derivative)	208,334	0.00 USD	—	SEC
CYTRX CORP	Dec 20, 2016	Award	2,325,581	0.43 USD	$1M	SEC
CYTRX CORP	Dec 20, 2016	AwardD (derivative)	1,250,000	0.00 USD	—	SEC
CYTRX CORP	Dec 19, 2016	AwardD (derivative)	1,250,000	0.00 USD	—	SEC
CYTRX CORP	Dec 17, 2015	AwardD (derivative)	1,000,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jun 23, 2015	AwardD (derivative)	100,000	0.00 USD	—	SEC
CATALYST SEMICONDUCTOR INC	Apr 28, 2015	AwardD (derivative)	200,000	0.00 USD	—	SEC
CYTRX CORP	Dec 16, 2014	AwardD (derivative)	600,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	ExerciseD (derivative)	-100,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	ExerciseD (derivative)	-50,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Sell	-150,000	5.92 USD	$888K	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Exercise	100,000	1.18 USD	$118K	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Exercise	50,000	2.31 USD	$115.5K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-50,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Exercise	200,000	1.18 USD	$236K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-200,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Sell	-250,000	6.13 USD	$1.5M	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Sell	-200,000	7.00 USD	$1.4M	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Exercise	50,000	0.72 USD	$36K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-200,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CYTRX CORP	Aug 13, 2020	Exercise	3,000,000	0.26 USD	$780K	SEC
CYTRX CORP	Aug 13, 2020	Other	-1,164,179	0.67 USD	$780K	SEC
CYTRX CORP	Aug 13, 2020	ExerciseD (derivative)	-3,000,000	0.00 USD	—	SEC
CYTRX CORP	Dec 17, 2019	AwardD (derivative)	3,000,000	0.00 USD	—	SEC
CYTRX CORP	Dec 19, 2017	Award	387,597	1.75 USD	$678.3K	SEC
CYTRX CORP	Dec 19, 2017	AwardD (derivative)	208,334	0.00 USD	—	SEC
CYTRX CORP	Dec 20, 2016	Award	2,325,581	0.43 USD	$1M	SEC
CYTRX CORP	Dec 20, 2016	AwardD (derivative)	1,250,000	0.00 USD	—	SEC
CYTRX CORP	Dec 19, 2016	AwardD (derivative)	1,250,000	0.00 USD	—	SEC
CYTRX CORP	Dec 17, 2015	AwardD (derivative)	1,000,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jun 23, 2015	AwardD (derivative)	100,000	0.00 USD	—	SEC
CATALYST SEMICONDUCTOR INC	Apr 28, 2015	AwardD (derivative)	200,000	0.00 USD	—	SEC
CYTRX CORP	Dec 16, 2014	AwardD (derivative)	600,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	ExerciseD (derivative)	-100,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	ExerciseD (derivative)	-50,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Sell	-150,000	5.92 USD	$888K	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Exercise	100,000	1.18 USD	$118K	SEC
RXI PHARMACEUTICALS CORP	Apr 9, 2014	Exercise	50,000	2.31 USD	$115.5K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-50,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Exercise	200,000	1.18 USD	$236K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-200,000	0.00 USD	—	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Sell	-250,000	6.13 USD	$1.5M	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Sell	-200,000	7.00 USD	$1.4M	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	Exercise	50,000	0.72 USD	$36K	SEC
RXI PHARMACEUTICALS CORP	Jan 22, 2014	ExerciseD (derivative)	-200,000	0.00 USD	—	SEC